DE69727691D1 - Verwendung von keratinocyten-wachstumsfaktor-2 - Google Patents

Verwendung von keratinocyten-wachstumsfaktor-2

Info

Publication number
DE69727691D1
DE69727691D1 DE69727691T DE69727691T DE69727691D1 DE 69727691 D1 DE69727691 D1 DE 69727691D1 DE 69727691 T DE69727691 T DE 69727691T DE 69727691 T DE69727691 T DE 69727691T DE 69727691 D1 DE69727691 D1 DE 69727691D1
Authority
DE
Germany
Prior art keywords
keratinocyten
growth factor
kgf
pancreas
gums
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69727691T
Other languages
English (en)
Other versions
DE69727691T2 (de
Inventor
L Lacey
R Ulich
M Danilenko
L Farrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE69727691D1 publication Critical patent/DE69727691D1/de
Application granted granted Critical
Publication of DE69727691T2 publication Critical patent/DE69727691T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69727691T 1996-10-15 1997-10-15 Verwendung von keratinocyten-wachstumsfaktor-2 Expired - Lifetime DE69727691T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2849596P 1996-10-15 1996-10-15
US28495P 1996-10-15
US3225396P 1996-12-06 1996-12-06
US32253P 1996-12-06
US3345796P 1996-12-10 1996-12-10
US33457P 1996-12-10
PCT/US1997/018667 WO1998016243A1 (en) 1996-10-15 1997-10-15 Uses of keratinocyte growth factor-2

Publications (2)

Publication Number Publication Date
DE69727691D1 true DE69727691D1 (de) 2004-03-25
DE69727691T2 DE69727691T2 (de) 2004-07-22

Family

ID=27363283

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69727691T Expired - Lifetime DE69727691T2 (de) 1996-10-15 1997-10-15 Verwendung von keratinocyten-wachstumsfaktor-2
DE69738336T Expired - Lifetime DE69738336T2 (de) 1996-10-15 1997-10-15 Verwendung von keratinocyte growth factor-2

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69738336T Expired - Lifetime DE69738336T2 (de) 1996-10-15 1997-10-15 Verwendung von keratinocyte growth factor-2

Country Status (10)

Country Link
EP (1) EP0941110B1 (de)
JP (1) JP4270580B2 (de)
AT (1) ATE259651T1 (de)
AU (1) AU725509B2 (de)
CA (1) CA2268741C (de)
DE (2) DE69727691T2 (de)
DK (1) DK0941110T3 (de)
ES (2) ES2216134T3 (de)
PT (1) PT941110E (de)
WO (1) WO1998016243A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
WO1999032135A1 (en) 1997-12-22 1999-07-01 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6242666B1 (en) 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
CA2375829A1 (en) * 1999-06-02 2000-12-07 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
NZ516897A (en) * 1999-07-02 2004-01-30 Human Genome Sciences Inc Polynucleotides and associated polypeptides for KGF-2 (also known as Fibroblast Growth Factor 12) to promote and accelerate internal and external wound healing
US20020001825A1 (en) * 2000-03-31 2002-01-03 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109122A (en) * 1993-03-26 2004-07-25 Amgen Inc Use of products from a keratinocytic growth factor for the preparation of medicinal preparations
DK0815115T3 (da) * 1995-02-14 2003-09-15 Human Genome Sciences Inc Keratinocytvækstfaktor-2
DE69633194T2 (de) * 1995-10-11 2005-09-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Kombination pdgf, kgf, igf und igfbp zur wundheilung
US6355862B1 (en) * 1995-10-13 2002-03-12 Purdue Research Foundation Fruit quality by inhibiting production of lipoxygenase in fruits

Also Published As

Publication number Publication date
JP4270580B2 (ja) 2009-06-03
AU725509B2 (en) 2000-10-12
ATE259651T1 (de) 2004-03-15
EP0941110B1 (de) 2004-02-18
DK0941110T3 (da) 2004-06-01
JP2001506586A (ja) 2001-05-22
CA2268741A1 (en) 1998-04-23
ES2216134T3 (es) 2004-10-16
AU5080698A (en) 1998-05-11
CA2268741C (en) 2007-04-24
WO1998016243A1 (en) 1998-04-23
DE69727691T2 (de) 2004-07-22
ES2297286T3 (es) 2008-05-01
DE69738336T2 (de) 2008-04-03
EP0941110A1 (de) 1999-09-15
PT941110E (pt) 2004-07-30
DE69738336D1 (de) 2008-01-10

Similar Documents

Publication Publication Date Title
NO953781D0 (no) Terapeutisk anvendelse av keratinocyttvekstfaktor
FR2721198B1 (fr) Prothèse implantable souple, utilisée en chirurgie pour l'augmentation de volume ou la reconstruction des tissus mous, notamment prothèse mammaire.
WO2005097219A3 (en) Ecm-based graft material
DK0637933T3 (da) Fremgangsmåde til behandling af organer og væv
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
DE69727691D1 (de) Verwendung von keratinocyten-wachstumsfaktor-2
DK1007566T3 (da) Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
CA2218333A1 (en) Surgical method for rejuvenating or reshaping body members by bone grafting _______________________________________________________
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
AU3401093A (en) Therapeutic agent for threatened abortion
Shields et al. Hydroxyapatite orbital implant after enucleation for intraocular tumors
RU1804797C (ru) Способ эндоссальной имплантации
RU97114014A (ru) Способ предупреждения послеоперационных осложнений при имплантации искусственного хрусталика
RU93035257A (ru) Способ лечения болезни пайра
RU2001104568A (ru) Способ ампутации конечности при облитерирующих заболеваниях артерий
ITMI20011185A0 (it) Protesi per l'occlusione dell'auricola cardiaca sinistra con impiantotranscatetere

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOVITRUM AB (PUBL), STOCKHOLM, SE